Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 44 Prostatic Neoplasms, Castration-Resistant 6 Neoplasm Metastasis 5 Metastatic Castration-resistant Prostate Cancer 4 Breast Neoplasms 4 Prostate Carcinoma Metastatic to the Bone 2 Neoplasms 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer (mCRPC) 2 Hormone Refractory Prostate Cancer 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bone Metastatic Castration-resistant Prostate Cancer 2 Thyroid Neoplasms 1 Prostate Cancer Metastatic to Bone 1 Prostate Adenocarcinoma 1 Pain 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Fractures, Bone 1 Fatigue 1 Castration-resistant Prostate Cancer 1 Castrate-Resistant Prostate Cancer 1 Bony Metastases From Castrate Refractory Prostate Cancer 1 Bone Neoplasms 1 Bone Metastases 1 Bone Diseases 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Goserelin 2 radium Ra 223 dichloride 1 enzalutamide 1 bicalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Radiosurgery 1 Leuprolide 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Prostate Cancer × radium Ra 223 dichloride × Clear all

NCT02925702 2020-01-27

PRORADIUM

Centro Nacional de Investigaciones Oncologicas CARLOS III

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡